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Abstract
Bilateral subthalamic nuclei deep brain stimulation (DBS) has been shown 
to be effective in treating motor symptoms of Parkinson’s disease. 
Numerous studies confirm the safety and efficacy of DBS. Complications 
of subthalamic nuclei DBS show a 1.2% risk of symptomatic intracerebral 
hemorrhage. There are few studies concerning the benefits of rehabilita-
tion after occurrence of intracerebral hemorrhage related to DBS. We 
report a patient who underwent an inpatient rehabilitation program 
because of complicated intracerebral hemorrhage after a DBS procedure. 
We observed significant improvement in locomotion and independence 
of daily activities after the program. We also review the current literature 
reporting complications following DBS. [Tzu Chi Med J 2010;22(1):61–64]
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1. Introduction
Parkinson’s disease (PD) is a neurodegenerative disor-
der characterized by tremors, rigidity, and akinesia [1]. 
In addition to medication, neurosurgery is an option 
to alleviate the Parkinsonian symptoms. Ablative ste-
reotactic surgery for a variety of movement disorders 
was adopted in the 1960s. Classical lesioning meth-
ods were mostly cast aside after highly effective drugs, 
such as levodopa (L-dopa), became available. L-dopa 
remains the gold standard for symptomatic treatment 
of PD. Nonetheless, patients with chronic L-dopa ther-
apy develop motor complications such as dyskinesias 
or motor fluctuations [2]. In the early 1990s, deep 
brain stimulation (DBS) began to be used to treat 
tremors. Owing to its adjustability, reversibility, and 
specificity, high frequency DBS of specific target areas 
is now accepted by clinicians as an established treat-
ment for medication-refractory PD patients [3,4]. 
Previous studies have suggested that bilateral sub-
thalamic DBS (STN-DBS) can improve all cardinal motor 
symptoms of PD including axial symptomatology [5–7]. 
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Although the procedure is relatively safe for all indi-
cated patients with PD, several centers have reported 
complications related to DBS procedures [8]. The 
risk of hemorrhage following stereotactic surgery 
ranges from 0.6% to 2.1% in previous reports [8–11]. 
However, few studies have investigated the outcome 
and benefits of rehabilitation for complicated intracra-
nial hemorrhage related to the operation of STN-DBS. 
We report, for the first time, a patient’s rehabilitative 
gains after complicated intracranial hemorrhage re-
lated to the DBS procedure in Taiwan, and review 
reports in the current literature on complications 
and prognosis after the procedure.
2. Case report
A 62-year-old man was diagnosed with PD 12 years 
ago. He also suffered ischemic heart disease and un-
derwent percutaneous coronary angioplasty in 2002. 
No antiplatelet or anticoagulation agents were given 
for his ischemic heart disease. He did not have a his-
tory of diabetes mellitus or hypertension. The initial 
presentation of PD included right hand clumsiness, 
micrographia, resting tremor, rigidity and bradykinesia. 
These symptoms had involved both hands for the 
past 9 years. For the past 8 years, it had been difficult 
for the patient to swallow solid food. He also had ob-
vious amentia demonstrated by memory loss in the 
previous 1–2 years.
Because the patient suffered these typical PD symp-
toms, he had taken L-dopa for the past 10 years. 
Initially, he benefited from a low dosage of L-dopa 
therapy, and the long duration of therapy allowed him 
to perform his daily activities independently. However, 
his disease progressed, and the L-dopa dose was pro-
gressively increased to control his symptoms. Unfor-
tunately, he demonstrated a marked “wearing-off” 
phenomenon, and the effect of the anti-Parkinsonian 
medication was not maintained for more than 3 
hours. Side effects of L-dopa, including auditory hal-
lucinations and constipation, were reported by the 
patient. He also had obvious difficulty in performing 
his daily activities and ambulation, which was caused 
by the progression of the PD. For example, he could 
only perform daily activities for 30 minutes after tak-
ing his medicine every morning. Owing to the progres-
sion of his PD and his intolerance to the side effects 
of current pharmacological therapy, he was admitted 
to our neurosurgical ward for DBS implantation. Three 
days later, preoperative brain computed tomography 
for navigation showed no active lesion. STN-DBS in-
sertion was performed and 7 hours later, the patient’s 
score on the Glasgow Coma Scale progressed from 
E1VtM4 to E3VtM6. Right hemiparesis in the patient 
was found by a neurosurgeon 7 hours after this opera-
tion. Manual muscle tests of both the right upper and 
lower limbs were graded 2. Emergency brain com-
puted tomography showed hemorrhage at the tip of 
the left electrode in the left cerebral peduncle (Fig. 1). 
The neurosurgeon prescribed mannitol to reduce in-
tracranial pressure. Because of the right hemiparesis, 
an inpatient rehabilitation program, including passive 
range of motion, stretch exercises, posture training, 
and muscle strengthening exercises, was started 
1 week later.
Approximately 1 month later, the patient was trans-
ferred to our rehabilitation ward. Initially, he needed 
minimal assistance to stand up and transfer from the 
bed to the wheelchair. Poor standing balance and en-
durance were also noted. His inpatient rehabilitation 
program included daily physical therapy and occupa-
tional therapy. The rehabilitation focused on improve-
ment of his muscle strength, ambulatory endurance, 
and stair climbing. The initial evaluation of his Barthel 
index score was 45. DBS remained turned off during 
this hospitalization. After 2 weeks of rehabilitation, 
the patient’s Barthel index score advanced to 55, and 
manual muscle tests of both the right upper and lower 
limbs were graded 4. At discharge from our rehabilita-
tion ward, he could walk more than 10 meters with his 
walker. He could also climb two flights of stairs inde-
pendently with supervision. He was discharged from 
the inpatient rehabilitation program after 15 days, 
when he had almost reached his initial rehabilitation 
goals. After his condition became stable, approxi-
mately 1 month later, he returned to our neurosurgical 
ward for a battery implantation and modification of 
his medication regimen and stimulator programming.
3. Discussion
DBS subthalamic nuclei surgery performed by expe-
rienced teams has a low risk of severe complications. 
Fig. 1 — Axial computed tomography of the brain shows 
acute bleeding in the left cerebral peduncle.
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The mortality rate in this type of surgery can reach 
up to 1.8% [12]. This mortality rate might be related 
to bleeding and the number of tracts made during the 
neurological exploration [13].
Complications of DBS include perioperative mortal-
ity (1.8%), permanent neurological deficits (0.6–6%), 
infections (3.6–5%), hardware complications (20.5%) 
and other complications (26.2%) [8,12,14–17]. Surgical 
complications of STN-DBS can be divided into those 
that are related to the surgical procedure and those 
that are hardware related. The most frequently re-
ported hardware-related complications are lead frac-
ture in the extracranial location, system infection, 
battery or connector problems, and lead migration 
[14]. Surgical complications include aborted proce-
dures, postoperative seizures, infections, and mis-
placed leads [8]. Our patient had intracerebral 
hemorrhage without evidence of hardware failure, ac-
cording to a postoperative image study. His complica-
tions may have been related to the surgical procedure.
Seijo and colleagues reported that 62% of their 
patients had no complications, 30% had one compli-
cation, and 8% had more than one complication [15]. 
Procedures were aborted in 5.14% of all cases, and 
there were misplaced leads in 2.2%, intracranial he-
morrhage in 3.3%, seizures in 4.7%, hardware compli-
cations in 1.8% and other complications in 5.1% [15]. 
The infection rate varies from 2.5% to 5.5% [8,16]. 
Vesper et al found that infections were significantly 
more frequent in older patients than in younger ones 
(p < 0.05) [17]. Based on a large-scale study of new 
DBS hardware implantations, the incidence of post-
operative hardware-related infection requiring further 
surgery was 4.5% [18].
A previous study showed that intracranial hemor-
rhage was present in nine patients, which equates to 
6.92% of all patients who received the stereotactic 
surgery [15]. The incidence of complicated intracra-
nial hemorrhage was 3.3% of all the DBS procedures. 
Among these nine patients, five patients had convul-
sions, two were asymptomatic, and one required urgent 
surgery. The last of the nine patients had an aborted 
procedure. Only one patient had long-term sequelae 
representing 0.36% of the DBS procedures [15].
The risk of symptomatic hemorrhage has been 
shown to be 1.2% and the risk of symptomatic hem-
orrhage resulting in permanent neurological deficit is 
0.6% [10]. There is still debate about the risk factors 
of hemorrhage during DBS. The patient’s age, diagno-
sis, sex, and number of microelectrode recording pen-
etrations do not show a significant correlation with 
occurrence of hematoma [10,15].
Sansur et al reported that hypertension, age, sex, 
and PD are risk factors for cerebral hemorrhage after 
DBS. A patient history of hypertension is the most sig-
nificant factor associated with symptomatic hemor-
rhage (p = 0.007) [19]. This finding was also confirmed 
by other studies [20,21]. In addition, Sansur et al 
found that five (8.6%) of the 58 patients with hyper-
tension experienced symptomatic hemorrhages [19]. 
In contrast, only two (1.0%) of 201 non-hypertensive 
patients had hemorrhages. PD was also significantly 
associated (p = 0.007) with hemorrhage, as five of 
the seven patients with symptomatic hemorrhaging 
were being treated for PD. Age was also significantly 
associated with hemorrhage (p = 0.01). The mean 
age of patients with symptomatic hemorrhage was 
65 years, while the mean age of the remaining pa-
tients was 41 years. However, in a subset analysis in 
which young patients with epilepsy were excluded 
from the calculation, age was no longer predictive of 
an increased risk of hemorrhage in adult patients un-
dergoing DBS. Sex was also significantly associated 
with hemorrhage, as all seven patients with hemor-
rhages were men (p = 0.04).
With regard to the prognosis of hemorrhage after 
DBS, Seijo et al reported only one patient who pre-
sented with persistent neurological sequelae (0.76%), 
consisting of a mild right hemiparesis secondary to 
intracerebral bleeding, which required emergency 
surgery [15]. In another study, patients with symp-
tomatic hemorrhage had significantly longer hospital 
stays (8.2 days vs. 2.7 days for other patients, p = 
0.0001) and were more likely to be discharged to a 
rehabilitation center or skilled nursing facility [19]. 
Therefore, a complicated hemorrhage indicated a 
worse outcome than an uncomplicated DBS proce-
dure. On the other hand, the majority of cases with 
spontaneous midbrain hemorrhage in the literature 
(35 patients, 53% of 66 reported cases) had minor 
neurological deficits, involving mainly cranial nerve 
III or IV or both [22]. In 10 cases (15%), moderate 
neurological deficits persisted and the patients re-
quired long-term care. Three patients (5%) died from 
spontaneous midbrain hemorrhage. The neurologi-
cal findings were normal at follow-up in 16 (24%) of 
the 66 reported cases.
There are many studies examining the outcome of 
inpatient rehabilitation following complicated intrac-
erebral hemorrhage related to DBS procedures. Our 
patient did not have a history of hypertension, which, 
as previously mentioned, may be the most significant 
risk factor for hemorrhage. However, he received DBS 
because of PD, and his sex increased the possibility of 
intracranial hemorrhage related to DBS. The rehabili-
tation program was customized for our patient, and 
was based on the severity and nature of the impair-
ments. Even with his obvious disabilities after compli-
cated hemorrhage, he showed great improvement in 
locomotion and activities of daily living after an inpa-
tient rehabilitation program.
In conclusion, intracerebral hemorrhage is one of 
the most significant complications associated with the 
application of DBS. According to previous reports, 
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hypertension, age, male sex, and PD are possible risk 
factors for cerebral hemorrhage after DBS. Thus the 
risk of this major complication may be reduced by in-
tensively controlling and monitoring the patient’s blood 
pressure. The incidence of persistent neurological se-
quelae after complicated intracerebral hemorrhage 
is relatively low compared with that after spontaneous 
midbrain hemorrhage. Because of early rehabilitative 
therapy, the patient avoided being bedridden and 
gained more independence in daily activities. We there-
fore believe that rehabilitative programs increase the 
chance of a favorable outcome after complicated in-
tracerebral hemorrhage related to STN-DBS, similar 
to cerebrovascular attack and traumatic brain injury.
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